Review
Marstacimab
In: Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006.
.
- PMID: 39626039
- Bookshelf ID: NBK609660
Item in Clipboard
Review
Marstacimab
Excerpt
No information is available on the clinical use of marstacimab during breastfeeding. Because marstacimab is a large protein molecule with a molecular weight of 146,000 Da, the amount in milk is likely to be very low. It is also likely to be partially destroyed in the infant's gastrointestinal tract and absorption by the infant is probably minimal. Until more data become available, marstacimab should be used with caution during breastfeeding, especially while nursing a newborn or preterm infant. Waiting for at least 2 weeks postpartum to resume therapy may minimize transfer to the infant.[1]
Similar articles
-
Qualitative evidence synthesis informing our understanding of people's perceptions and experiences of targeted digital communication.Cochrane Database Syst Rev. 2019 Oct 23;10(10):ED000141. doi: 10.1002/14651858.ED000141. Cochrane Database Syst Rev. 2019. PMID: 31643081 Free PMC article.
-
Depressing time: Waiting, melancholia, and the psychoanalytic practice of care.In: Kirtsoglou E, Simpson B, editors. The Time of Anthropology: Studies of Contemporary Chronopolitics. Abingdon: Routledge; 2020. Chapter 5. In: Kirtsoglou E, Simpson B, editors. The Time of Anthropology: Studies of Contemporary Chronopolitics. Abingdon: Routledge; 2020. Chapter 5. PMID: 36137063 Free Books & Documents. Review.
-
Golimumab.2024 Nov 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2024 Nov 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000713 Free Books & Documents. Review.
-
Tranexamic acid for preventing postpartum haemorrhage after caesarean section.Cochrane Database Syst Rev. 2024 Nov 13;11(11):CD016278. doi: 10.1002/14651858.CD016278. Cochrane Database Syst Rev. 2024. PMID: 39535297 Free PMC article. Review.
-
Infliximab for maintenance of medically-induced remission in Crohn's disease.Cochrane Database Syst Rev. 2024 Feb 19;2(2):CD012609. doi: 10.1002/14651858.CD012609.pub2. Cochrane Database Syst Rev. 2024. PMID: 38372447 Free PMC article. Review.
References
-
- Krysko KM, Dobson R, Alroughani R, et al. Family planning considerations in people with multiple sclerosis. Lancet Neurol 2023;22:350-66. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
